{
    "Trade/Device Name(s)": [
        "hCG Urine Test Strip",
        "hCG Urine Test Cassette",
        "hCG Urine Test Midstream"
    ],
    "Submitter Information": "Safecare Biotech (Hangzhou) Co., Ltd.",
    "510(k) Number": "K200133",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043443"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "June 29, 2020",
    "Summary Letter Received Date": "June 29, 2020",
    "Submission Date": "August 12, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow sandwich assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Strip",
        "Cassette",
        "Midstream"
    ],
    "Document Summary": "FDA 510(k) summary for hCG Urine Test Strip, Cassette, and Midstream qualitative pregnancy tests using immunochromatographic lateral flow technology",
    "Indications for Use Summary": "Qualitative detection of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy",
    "fda_folder": "Clinical Chemistry"
}